 |
 |

CLINICIANS CORNER
Tumor-Induced Osteomalacia
Suzanne M. Jan de Beur, MD
JAMA. 2005;294:1260-1267.
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic form of renal phosphate wasting that results in severe hypophosphatemia, a defect in vitamin D metabolism, and osteomalacia. This debilitating disorder is illustrated by the clinical presentation of a 55-year-old woman with progressive fatigue, weakness, and muscle and bone pain with fractures. After a protracted clinical course and extensive laboratory evaluation, tumor-induced osteomalacia was identified as the basis of her clinical presentation. In this article, the distinctive clinical characteristics of this syndrome, the advances in diagnosis of TIO, and new insights into the pathophysiology of this disorder are discussed.
Author Affiliation: Department of Medicine, Johns Hopkins University School of Medicine, and Department of Endocrinology, Johns Hopkins Bayview Medical Center, Baltimore, Md.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Question Well Put
Reilly et al.
NEJM 2009;360:1446-1451.
FULL TEXT
Rapid Detection of Intact FGF-23 in Tumor Tissue from Patients with Oncogenic Osteomalacia
Mannstadt et al.
Clin. Chem. 2008;54:1252-1254.
FULL TEXT
Determination of the Elimination Half-Life of Fibroblast Growth Factor-23
Khosravi et al.
J. Clin. Endocrinol. Metab. 2007;92:2374-2377.
ABSTRACT
| FULL TEXT
Update in Osteoporosis and Metabolic Bone Disorders
Shoback
J. Clin. Endocrinol. Metab. 2007;92:747-753.
ABSTRACT
| FULL TEXT
|